Diagnostics Revolutions

Diagnostics Revolutions
  • Pininvest Analysis

By highlighting well respected companies providing systems for in-vitro diagnostics, including gene sequencing machines, and related services, we focus on advanced medical equipment used in clinical applications, in laboratories and in research.

The fastest growing areas, gene analysis techniques and splicing applied to fields of human identity testing, oncology research, infectious disease research, pharmacogenomics, and inherited disease boost research and product innovation in molecular biology (identifying potential drug targets), microbiology (defining how organisms evolve), medicine (tracking genetic diseases) and plant sciences

The breath of the applications with potential breakthrough in areas as diverse as healthcare, agriculture or environmental protection has opened vast opportunities for start-up companies applying the new technologies… but major uncertainties about commercial break-through leaves the potential investor exposed to extreme risk situations

To service the diagnostics market (evaluated at $ 60 billion and expected to continue to grow by 4% during the coming 5 years), manufacturers of the advanced medical equipment are placed on a strong footing

Diagnostics Revolutions • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Momentum Vol. Risk Contrib. MDD
 
Accelerate Diagnostics AXDX NASDAQ Health Care Lab Analytical Instruments USD 8.75 519 M -6.5% Weak Up 86%   5% -62%
Agilent Technologies A NYSE Health Care Medical Laboratories & Research USD 143.53 44 B 67.3% Neutral 22%   2% -12%
Bio-Rad Laboratories BIO NYSE Health Care Lab Analytical Instruments USD 601.68 18 B 34.0% Neutral 32%   3% -20%
Bio-Techne TECH NASDAQ Health Care Diagnostics USD 443.94 17 B 80.9% Neutral 35%   3% -16%
Bruker Corporation BRKR NASDAQ Health Care Lab Analytical Instruments USD 73.52 11 B 81.1% Neutral 29%   3% -17%
Cancer Genetics CGIX NASDAQ Health Care Diagnostics USD 4.61 11 M 41.8% Sharp Down 149%   8% -65%
Danaher DHR NYSE Conglomerates Industrial Conglomerates USD 247.02 176 B 47.0% Neutral 24%   2% -14%
Exact Sciences EXAS NASDAQ Health Care Diagnostics USD 121.89 21 B 42.8% Neutral 57%   5% -40%
Guardant Health GH NASDAQ Health Care Diagnostics USD 120.94 12 B 56.9% Sharp Down 47%   5% -39%
HTG Molecular Diagnostics HTGM NASDAQ Health Care Medical Devices USD 4.67 29 M -52.8% Neutral 80%   4% -72%
Illumina ILMN NASDAQ Health Care Gene Editing - Cell Therapies USD 453.17 66 B 32.7% Weak Up 40%   4% -27%
Laboratory Corporation Of America LH NYSE Health Care Diagnostics USD 258.55 25 B 54.1% Neutral 25%   2% -14%
Lantheus Holdings LNTH NASDAQ Health Care Medical Consumables & Intermediates USD 24.30 1.6 B 86.8% Weak Up 43%   2% -34%
NanoString Technologies NSTG NASDAQ Health Care Diagnostics USD 59.31 2.6 B 92.9% Neutral 64%   7% -42%
NeoGenomics NEO NASDAQ Health Care Gene Editing - Cell Therapies USD 43.10 5.0 B 59.5% Neutral 46%   5% -39%
OPKO Health OPK NASDAQ Health Care Diagnostics USD 3.72 2.5 B 50.0% Neutral 79%   7% -50%
Pacific Biosciences of California PACB NASDAQ Health Care Medical Technology USD 29.22 5.6 B 718.5% Neutral 86%   9% -56%
PerkinElmer PKI NYSE Health Care Medical Laboratories & Research USD 146.81 16 B 51.3% Neutral 32%   3% -25%
Quest Diagnostics DGX NYSE Health Care Diagnostics USD 127.29 17 B 16.6% Neutral 25%   2% -18%
Quidel QDEL NASDAQ Health Care Diagnostics USD 114.77 4.9 B -33.2% Weak Down 79%   6% -66%
Sonic Healthcare SKHHY OTC Health Care Diagnostics USD 27.36 - 46.8% Neutral 26%   1% -13%
Thermo Fisher Scientific TMO NYSE Health Care Lab Analytical Instruments USD 465.15 183 B 37.2% Neutral 27%   3% -17%
Veracyte VCYT NASDAQ Health Care Diagnostics USD 36.14 2.4 B 48.8% Sharp Down 73%   8% -60%
Waters WAT NYSE Health Care Lab Analytical Instruments USD 336.58 21 B 81.4% Strong Up 27%   2% -17%